Replies to post #3006 on BioCurex, Inc.(fka BOCX)

[Kag]

Erthing,

All that appears to be required is one test implemented to run on Abbott's automated analyzer that will detect the presence of the RECAF receptors on the surface of malignant cells found in blood samples.

The announcement of the Abbott deal first milestone has to be very close. kag